We are a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in the areas of Immunology and Rare Disease.
Our highly targeted clinical-stage therapeutics are founded on a strong scientific and clinical rationale that may enable accelerated clinical development and increased probability of clinical and regulatory success.
We are rapidly advancing a rich pipeline with the potential for broad clinical utility across Immunology and Rare Genetic Diseases.